The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heinzel, F. P.
Right arrow Articles by Pearlman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heinzel, F. P.
Right arrow Articles by Pearlman, E.

The Journal of Immunology, Vol 155, Issue 2 730-739, Copyright © 1995 by American Association of Immunologists

ARTICLES

Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice

FP Heinzel, RM Rerko, F Ahmed and E Pearlman
Division of Geographic Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

We investigated the mechanisms by which treatment with anti-IL-12 Ab prevents cure of infection with Leishmania major in resistant C57BL/6 mice. Consistent with delayed production of IL-12, anti-IL-12 Abs could be administered as late as 2 wk after infection to exacerbate disease. Starting at 2 wk of infection, the cultured lymph node cells from mice treated with either polyclonal or monoclonal anti-IL-12 Abs persistently generated 3- to 10-fold more IL-4 and IL-10 in response to L. major Ag compared with cells from mice receiving preimmune goat IgG. Reciprocal decreases in Ag-specific IFN-gamma production were observed in mice receiving anti-IL-12 Abs. A similar reversal of IFN-gamma and IL-4 production accompanied progressive disease induced by pretreatment with a single dose of anti-IFN-gamma mAb. Although IFN-gamma production was suppressed for up to 4 wk in mice treated with monoclonal anti-IL- 12 or anti-IFN-gamma, coadministration of neutralizing anti-IL-4 IgG reversed progressive illness. These findings demonstrate that IL-12 produced in vivo is necessary for both the emergence of IFN-gamma producing cells and the down-regulation of Th2 cell responses during murine leishmaniasis. Furthermore, the uninhibited production of IL-4 was required to sustain progressive infection initiated by the decreased IFN-gamma synthesis observed in anti-IL-12 and anti-IFN-gamma- treated mice.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
F. J. S. Rocha, U. Schleicher, J. Mattner, G. Alber, and C. Bogdan
Cytokines, Signaling Pathways, and Effector Molecules Required for the Control of Leishmania (Viannia) braziliensis in Mice
Infect. Immun., August 1, 2007; 75(8): 3823 - 3832.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Soares, H. Waechter, N. Glaichenhaus, E. Mougneau, H. Yagita, O. Mizenina, D. Dudziak, M. C. Nussenzweig, and R. M. Steinman
A subset of dendritic cells induces CD4+ T cells to produce IFN-{gamma} by an IL-12-independent but CD70-dependent mechanism in vivo
J. Exp. Med., May 14, 2007; 204(5): 1095 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L. J Ma, E. A Guzman, A. DeGuzman, H K. Muller, A. M Walker, and L. B Owen
Local cytokine levels associated with delayed-type hypersensitivity responses: modulation by gender, ovariectomy, and estrogen replacement
J. Endocrinol., May 1, 2007; 193(2): 291 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. M. Theodos, R. V. Morris, J. V. Bishop, J. D. Jones, W. R. McMaster, and R. G. Titus
Characterization of an I-E-Restricted, gp63-Specific, CD4-T-Cell Clone from Leishmania major-Resistant C3H Mice That Secretes Type 2 Cytokines and Exacerbates Infection with L. major
Infect. Immun., August 1, 2004; 72(8): 4486 - 4493.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. M. Padigel, N. Kim, Y. Choi, and J. P. Farrell
TRANCE-RANK Costimulation is Required for IL-12 Production and the Initiation of a Th1-Type Response to Leishmania major Infection in CD40L-Deficient Mice
J. Immunol., November 15, 2003; 171(10): 5437 - 5441.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. A. Garhart, J. G. Nedrud, F. P. Heinzel, N. E. Sigmund, and S. J. Czinn
Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4
Infect. Immun., June 1, 2003; 71(6): 3628 - 3633.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. C. Gavrilescu and E. Y. Denkers
Interleukin-12 p40- and Fas Ligand-Dependent Apoptotic Pathways Involving STAT-1 Phosphorylation Are Triggered during Infection with a Virulent Strain of Toxoplasma gondii
Infect. Immun., May 1, 2003; 71(5): 2577 - 2583.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh
T Cells Primed by Leishmania major Infection Cross-React with Alloantigens and Alter the Course of Allograft Rejection
J. Immunol., October 1, 2002; 169(7): 3686 - 3693.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Aseffa, A. Gumy, P. Launois, H. R. MacDonald, J. A. Louis, and F. Tacchini-Cottier
The Early IL-4 Response to Leishmania major and the Resulting Th2 Cell Maturation Steering Progressive Disease in BALB/c Mice Are Subject to the Control of Regulatory CD4+CD25+ T Cells
J. Immunol., September 15, 2002; 169(6): 3232 - 3241.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Y. Park, B. Hondowicz, M. Kopf, and P. Scott
The Role of IL-12 in Maintaining Resistance to Leishmania major
J. Immunol., June 1, 2002; 168(11): 5771 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Launois, A. Gumy, H. Himmelrich, R. M. Locksley, M. Rocken, and J. A. Louis
Rapid IL-4 Production by Leishmania Homolog of Mammalian RACK1-Reactive CD4+ T Cells in Resistant Mice Treated Once with Anti-IL-12 or -IFN-{gamma} Antibodies at the Onset of Infection with Leishmania major Instructs Th2 Cell Development, Resulting in Nonhealing Lesions
J. Immunol., May 1, 2002; 168(9): 4628 - 4635.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. L. Compton and J. P. Farrell
CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major
J. Immunol., February 1, 2002; 168(3): 1302 - 1308.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Y. Karulin, M. D. Hesse, H. C. Yip, and P. V. Lehmann
Indirect IL-4 Pathway in Type 1 Immunity
J. Immunol., January 15, 2002; 168(2): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Chen, P. A. Darrah, and D. M. Mosser
Vaccination against the Intracellular Pathogens Leishmania major and L. amazonensis by Directing CD40 Ligand to Macrophages
Infect. Immun., May 1, 2001; 69(5): 3255 - 3263.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Wang, Y. Fan, X. Han, J. Yang, L. Bilenki, and X. Yang
IL-12-Dependent Vascular Cell Adhesion Molecule-1 Expression Contributes to Airway Eosinophilic Inflammation in a Mouse Model of Asthma-Like Reaction
J. Immunol., February 15, 2001; 166(4): 2741 - 2749.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. B. Kremer, M. P. Gould, K. D. Cooper, and F. P. Heinzel
Pretreatment with Recombinant Flt3 Ligand Partially Protects against Progressive Cutaneous Leishmaniasis in Susceptible BALB/c Mice
Infect. Immun., February 1, 2001; 69(2): 673 - 680.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Streit, T. J. Recker, F. G. Filho, S. M. Beverley, and M. E. Wilson
Protective Immunity Against the Protozoan Leishmania chagasi Is Induced by Subclinical Cutaneous Infection with Virulent But Not Avirulent Organisms
J. Immunol., February 1, 2001; 166(3): 1921 - 1929.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. V. C. Lonardoni, M. Russo, and S. Jancar
Essential Role of Platelet-Activating Factor in Control of Leishmania (Leishmania) amazonensis Infection
Infect. Immun., November 1, 2000; 68(11): 6355 - 6361.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Lira, M. Doherty, G. Modi, and D. Sacks
Evolution of Lesion Formation, Parasitic Load, Immune Response, and Reservoir Potential in C57BL/6 Mice following High- and Low-Dose Challenge with Leishmania major
Infect. Immun., September 1, 2000; 68(9): 5176 - 5182.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Quinones, S. K. Ahuja, P. C. Melby, L. Pate, R. L. Reddick, and S. S. Ahuja
Preformed Membrane-Associated Stores of Interleukin (Il)-12 Are a Previously Unrecognized Source of Bioactive IL-12 That Is Mobilized within Minutes of Contact with an Intracellular Parasite
J. Exp. Med., August 21, 2000; 192(4): 507 - 516.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. S. Heeger, T. Forsthuber, C. Shive, E. Biekert, C. Genain, H. H. Hofstetter, A. Karulin, and P. V. Lehmann
Revisiting Tolerance Induced by Autoantigen in Incomplete Freund's Adjuvant
J. Immunol., June 1, 2000; 164(11): 5771 - 5781.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Ohkusu, T. Yoshimoto, K. Takeda, T. Ogura, S.-i. Kashiwamura, Y. Iwakura, S. Akira, H. Okamura, and K. Nakanishi
Potentiality of Interleukin-18 as a Useful Reagent for Treatment and Prevention of Leishmania major Infection
Infect. Immun., May 1, 2000; 68(5): 2449 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Himmelrich, P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Rocken, and J. A. Louis
In BALB/c Mice, IL-4 Production During the Initial Phase of Infection with Leishmania major Is Necessary and Sufficient to Instruct Th2 Cell Development Resulting in Progressive Disease
J. Immunol., May 1, 2000; 164(9): 4819 - 4825.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N.-H. Cho, S.-Y. Seong, M.-S. Huh, T.-H. Han, Y.-S. Koh, M.-S. Choi, and I.-S. Kim
Expression of Chemokine Genes in Murine Macrophages Infected with Orientia tsutsugamushi
Infect. Immun., February 1, 2000; 68(2): 594 - 602.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. L. Martin, C. L. King, E. Pearlman, E. Strine, and F. P. Heinzel
IFN-{gamma} Is Necessary But Not Sufficient for Anti-CD40 Antibody-Mediated Inhibition of the Th2 Response to Schistosoma mansoni Eggs
J. Immunol., January 15, 2000; 164(2): 779 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. P. Heinzel and R. A. Maier Jr.
Interleukin-4-Independent Acceleration of Cutaneous Leishmaniasis in Susceptible BALB/c Mice following Treatment with Anti-CTLA4 Antibody
Infect. Immun., December 1, 1999; 67(12): 6454 - 6460.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. C. Santiago, M. A. P. Oliveira, E. A. Bambirra, A. M. C. Faria, L. C. C. Afonso, L. Q. Vieira, and R. T. Gazzinelli
Coinfection with Toxoplasma gondii Inhibits Antigen-Specific Th2 Immune Responses, Tissue Inflammation, and Parasitism in BALB/c Mice Infected with Leishmania major
Infect. Immun., September 1, 1999; 67(9): 4939 - 4944.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. P. Heinzel and R. M. Rerko
Cure of Progressive Murine Leishmaniasis: Interleukin 4 Dominance Is Abolished by Transient CD4+ T Cell Depletion and T Helper Cell Type 1-selective Cytokine Therapy
J. Exp. Med., June 21, 1999; 189(12): 1895 - 1906.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E. E. Sercarz, F. L. Graham, J. Gauldie, and T. A. Braciak
A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice
J. Immunol., January 15, 1999; 162(2): 753 - 760.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
J Alexander, A. Satoskar, and D. Russell
Leishmania species: models of intracellular parasitism
J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
M. E. Wilson, B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan
The Importance of TGF-{beta} in Murine Visceral Leishmaniasis
J. Immunol., December 1, 1998; 161(11): 6148 - 6155.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. Mastroeni, J. A. Harrison, J. H. Robinson, S. Clare, S. Khan, D. J. Maskell, G. Dougan, and C. E. Hormaeche
Interleukin-12 Is Required for Control of the Growth of Attenuated Aromatic-Compound-Dependent Salmonellae in BALB/c Mice: Role of Gamma Interferon and Macrophage Activation
Infect. Immun., October 1, 1998; 66(10): 4767 - 4776.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-M. Hu, W. J. Urba, and B. A. Fox
Gene-Modified Tumor Vaccine with Therapeutic Potential Shifts Tumor-Specific T Cell Response from a Type 2 to a Type 1 Cytokine Profile
J. Immunol., September 15, 1998; 161(6): 3033 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. P. Heinzel, R. M. Rerko, A. M. Hujer, and R. A. Maier Jr.
Increased Capacity for Interleukin-2 Synthesis Parallels Disease Progression in Mice Infected with Leishmania major
Infect. Immun., September 1, 1998; 66(9): 4537 - 4540.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Keane-Myers, M. Wysocka, G. Trinchieri, and M. Wills-Karp
Resistance to Antigen-Induced Airway Hyperresponsiveness Requires Endogenous Production of IL-12
J. Immunol., July 15, 1998; 161(2): 919 - 926.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Sjolander, T. M. Baldwin, J. M. Curtis, and E. Handman
Induction of a Th1 Immune Response and Simultaneous Lack of Activation of a Th2 Response Are Required for Generation of Immunity to Leishmaniasis
J. Immunol., April 15, 1998; 160(8): 3949 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Piccotti, K. Li, S. Y. Chan, J. Ferrante, J. Magram, E. J. Eichwald, and D. K. Bishop
Alloantigen-Reactive Th1 Development in IL-12-Deficient Mice
J. Immunol., February 1, 1998; 160(3): 1132 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. A. Kernacki, D. J. Goebel, M. S. Poosch, and L. D. Hazlett
Early Cytokine and Chemokine Gene Expression during Pseudomonas aeruginosa Corneal Infection in Mice
Infect. Immun., January 1, 1998; 66(1): 376 - 379.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. S. Chu, O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
J. Exp. Med., November 17, 1997; 186(10): 1623 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
N. A. Giese, L. Gabriele, T. M. Doherty, D. M. Klinman, L. Tadesse-Heath, C. Contursi, S. L. Epstein, and H. C. Morse III
Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression
J. Exp. Med., November 3, 1997; 186(9): 1535 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. W. Murray, J. Hariprashad, and R. L. Coffman
Behavior of Visceral Leishmania donovani in an Experimentally Induced T Helper Cell 2 (Th2)-Associated Response Model
J. Exp. Med., March 3, 1997; 185(5): 867 - 874.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. R. Brown, K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner
T Helper Subset Differentiation in the Absence of Invariant Chain
J. Exp. Med., January 6, 1997; 185(1): 31 - 42.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.